Our identification of the first case of human ARPKD caused by a CYS1 variant confirms the relevance of the cpk mouse as an ARPKD model yielding important insights into molecular mechanisms underlying disease pathobiology. This evidence concerns the gene CYS1 and autosomal recessive polycystic kidney disease.